Literature DB >> 9572674

Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-L-carnitine.

K Qureshi1, K V Rao, I A Qureshi.   

Abstract

Sparse-fur (spf) mouse is the ideal animal model to study the neuropathology of congenital ornithine transcarbamylase (OTC) deficiency. Our current hypothesis implies that an ammonia-induced depletion of energy metabolism in the spf mouse, could be due to a reduction in the activities of the enzymes of the electron transport chain and a treatment with acetyl-L-carnitine could normalize this abnormality. We also hypothesized that there might be a differential degree of inhibition in synaptosomal and non-synaptic mitochondria, for the enzymes of the electron transport chain, caused by congenital hyperammonemia. We have therefore measured the activities of NADH-cytochrome C oxidoreductase, succinate cytochrome C oxidoreductase and cytochrome C oxidase in synaptosomes and non-synaptic mitochondria, isolated from spf mice and CD-1 controls with and without acetyl-L-carnitine treatment. Our results indicate a significant reduction (19-34%) in the activities of these complexes in synaptosomes in untreated spf mice, whereas in non-synaptic mitochondria, there was a tendency for the activities to decrease. Acetyl-L-carnitine treatment enhanced these activities (15-64%) for all the three enzyme complexes and its effect was more prominent on succinate cytochrome C oxidoreductase activity (64%). These studies point out that: (a) ammonia-induced disturbances in the energy metabolism could be more pronounced in neuronal mitochondria, and (b) the effect of acetyl-L-carnitine on the restoration of cerebral ATP in hyperammonemia could be through an enhancement of the activities of various electron transport chain enzymes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572674     DOI: 10.1023/a:1022406911604

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  Respiratory inhibition of TCA cycle and control of glutamic acid synthesis by ammonia in rat liver mitochondria.

Authors:  N KATUNUMA; M OKADA
Journal:  Biochem Biophys Res Commun       Date:  1963-07-26       Impact factor: 3.575

Review 2.  Urea cycle disorders: diagnosis, pathophysiology, and therapy.

Authors:  S W Brusilow; N E Maestri
Journal:  Adv Pediatr       Date:  1996

3.  Changes in non-synaptosomal and synaptosomal mitochondrial membrane-linked enzymatic activities after transient cerebral ischemia.

Authors:  C Cafè; C Torri; S Gatti; D Adinolfi; P Gaetani; R Rodriguez Y Baena; F Marzatico
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

4.  Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease.

Authors:  I A Qureshi; J Letarte; R Ouellet
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

5.  Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion.

Authors:  K V Rao; Y R Mawal; I A Qureshi
Journal:  Neurosci Lett       Date:  1997-03-14       Impact factor: 3.046

6.  Na+,K(+)-ATPase activities are increased in brain in both congenital and acquired hyperammonemic syndromes.

Authors:  L Ratnakumari; R Audet; I A Qureshi; R F Butterworth
Journal:  Neurosci Lett       Date:  1995-09-08       Impact factor: 3.046

7.  Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons.

Authors:  S P Raps; J C Lai; L Hertz; A J Cooper
Journal:  Brain Res       Date:  1989-07-31       Impact factor: 3.252

8.  Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine.

Authors:  R E Rosenthal; R Williams; Y E Bogaert; P R Getson; G Fiskum
Journal:  Stroke       Date:  1992-09       Impact factor: 7.914

9.  Neuron-specific mitochondrial degeneration induced by hyperammonemia and octanoic acidemia.

Authors:  L R Drewes; R L Leino
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

10.  Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

View more
  16 in total

Review 1.  Signaling factors in the mechanism of ammonia neurotoxicity.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

2.  Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.

Authors:  Daniel B Larach; W Andrew Kofke; Peter Le Roux
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

3.  Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

Authors:  Michele Malaguarnera; Marco Vacante; Massimo Motta; Maria Giordano; Giulia Malaguarnera; Rita Bella; Giuseppe Nunnari; Liborio Rampello; Giovanni Pennisi
Journal:  Metab Brain Dis       Date:  2011-08-26       Impact factor: 3.584

4.  Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.

Authors:  Saurabh Dhanda; Aditya Sunkaria; Avishek Halder; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2017-11-14       Impact factor: 3.584

Review 5.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

6.  Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by acetaminophen.

Authors:  Jordana P Panatto; Isabela C Jeremias; Gabriela K Ferreira; Andrea C Ramos; Natalia Rochi; Cinara L Gonçalves; Juliana F Daufenbach; Gabriela C Jeremias; Milena Carvalho-Silva; Gislaine T Rezin; Giselli Scaini; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2011-01-04       Impact factor: 3.396

7.  Thioacetamide-induced fulminant hepatic failure induces cerebral mitochondrial dysfunction by altering the electron transport chain complexes.

Authors:  Kiranmai Chadipiralla; Pallu Reddanna; Radhakrishna M Chinta; Pichili Vijaya Bhaskar Reddy
Journal:  Neurochem Res       Date:  2011-08-31       Impact factor: 3.996

Review 8.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

9.  Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress.

Authors:  Gangarao Davuluri; Allawy Allawy; Samjhana Thapaliya; Julie H Rennison; Dharmvir Singh; Avinash Kumar; Yana Sandlers; David R Van Wagoner; Chris A Flask; Charles Hoppel; Takhar Kasumov; Srinivasan Dasarathy
Journal:  J Physiol       Date:  2016-10-23       Impact factor: 5.182

Review 10.  Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.

Authors:  Nathan J Shores; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.